Abstract
Current clinical guidelines recommend mutation analysis for select codons in KRAS and NRAS exons 2, 3, and 4 and BRAF V600E to guide therapy selection......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
